Exploring the landscape of Lipid Nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids
- PMID: 39669003
- PMCID: PMC11635012
- DOI: 10.1016/j.ijpx.2024.100305
Exploring the landscape of Lipid Nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids
Abstract
Lipid nanoparticles (LNPs) have emerged as promising carriers for delivering therapeutic agents, including mRNA-based immunotherapies, in various biomedical applications. The use of LNPs allows for efficient delivery of drugs, resulting in enhanced targeted delivery to specific tissues or cells. These LNPs can be categorized into several types, including liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and lipid-polymer hybrid nanoparticles. The preparation of LNPs involves the manipulation of their structural, dimensional, compositional, and physical characteristics via the use of different methods in the industry. Lipids used to construct LNPs can also be derived from various biological sources, such as natural lipids extracted from plants, animals, or microorganisms. This review dives into the different types of LNPs and their preparation methods. More importantly, it discusses all possible biological sources that are known to supply lipids for the creation of LNPs. Natural lipid reservoirs have surfaced as promising sources for generating LNPs. The use of LNPs in drug delivery is expected to increase significantly in the coming years. Herein, we suggest some environmentally friendly and biocompatible sources that can produce lipids for future LNPs production.
Keywords: Biological sources; Biotechnology; Drug delivery; Lipid nanoparticles; Lipids.
© 2024 The Authors. Published by Elsevier B.V.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Abdulaziz Mohammed Aldayel reports financial support was provided by Saudi Arabia Research Development and Innovation Authority. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Abdel-baky A., Hashima A.A., Ashraf E., Hamdy M., Wardani A.H.A. 2020. Pharmaceutical uses of animal byproducts. Unpublished. - DOI
-
- Abid N., Khan A.M., Shujait S., Chaudhary K., Ikram M., Imran M., et al. Synthesis of nanomaterials using various top-down and bottom-up approaches, influencing factors, advantages, and disadvantages: a review. Adv. Colloid Interf. Sci. 2022;300 - PubMed
-
- Ahmed K.S., Hussein S.A., Ali A.H., Korma S.A., Lipeng Q., Jinghua C. Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. J. Drug Target. 2019;27:742–761. - PubMed
-
- Aiuto B., Cirrincione S., Giuffrida M.G., Cavallarin L., Portesi C., Rossi A.M., et al. Not Available. Mol. Nutr. Food Res. 2024;68 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
